GlassScriptPhysician profile
Jonathon L Park
NPI 1588649289
$642.67
in general payments reported to CMS, 2019-2025
16 companies · $67.44 in 2025
The $67.44 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.10 · 2020: $159 · 2021: $39.38 · 2022: $244 · 2023: $36.14 · 2025: $67.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.60 · Education: $31.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.60 |
| Education | $31.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $174.48 | 2022 | |
| Jazz Pharmaceuticals INC. | $121.00 | 2020 | |
| Mylan Specialty L.P. | $67.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $59.06 | 2022-2025 | Breztri |
| Amgen INC. | $46.05 | 2019-2025 | Evenity |
| Kerecis Limited | $22.02 | 2021 | |
| Abbvie INC. | $21.30 | 2025 | |
| Novo Nordisk INC | $18.19 | 2023 | Ozempic, Rybelsus |
| Lundbeck LLC | $17.95 | 2023 | Rexulti |
| Lilly USA, LLC | $16.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.83 | 2019 | |
| Amarin Pharma, INC. | $13.64 | 2020 | |
| Glaxosmithkline, LLC. | $13.20 | 2020 | |
| Merck Sharp & Dohme LLC | $12.61 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.